All lobbying filings

PENN AVENUE PARTNERS

Lobbying for ALKERMES, INC. · Pharmaceutical manufacturing and biopharmaceutical company.

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 9, 2025

Income

$70,000.00

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Lobbyists on this filing 4

TIMOTHY FARRELL HANNEGAN

Previously held: U.S. General Accounting Office
JERR ROSENBAUM

Previously held: Legislative Director, Sen. John Cornyn; Chief of Staff, Rep. Robert Hurt; Chief of Staff, Rep. Jack Kingston; Chief of Staff, Rep. Virgil Goode
CHRISTINA MCGARRY DAVID

Previously held: Legislative Assistant / Scheduler, Rep. Mario Diaz-Balart; Intern, Rep. Doc Hastings
JAY SULZMANN

Previously held: Legislative Director/Health Policy Advisor, Sen. Johnny Isakson; Sr. Policy Advisor/LA/LC/SA, Rep. Wally Herger

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 3

HOUSE OF REPRESENTATIVES
SENATE
Veterans Affairs, Dept of (VA)

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 1

HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Lobbying activity 1

Pharmacy

Regulatory and legislative issues impacting Alkermes. Appropriations. H.R.1 - One Big Beautiful Bill Act.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.